Florida Cancer Affiliates
Print Text Size
  • Home
  • About Us
  • Careers
  • Contact Us
  • Menu
  • For
    Patients
  • Treatments
    & Services
  • Locations
    & Physicians
  • Cancers &
    Blood Diseases
  • Clinical Trials
    & Research
  • For Medical
    Professionals
  • Pharmacy
  • About Us
  • Careers
  • Contact Us

Medical News on Cancer

Outcomes Of Robotic Surgery: Data Presented At Head And Neck Cancer Annual Meeting

Jul 30, 2012

Predictors of disease severity in human papillomavirus-derived head and neck cancer, tobacco use, and the dramatic benefits of robotic surgery in people with head and neck cancer are among landmark research presented by Mount Sinai School of Medicine at the Eighth International Conference on Head and Neck Cancer. The meeting took place from July 21-25, 2012 in Toronto... Read More

For Metastatic Melanoma, Should High-Dose Interleukin-2 Continue To Be The Treatment Of Choice?

Jul 29, 2012

Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective... Read More

Malignant Melanoma Drug Trabedersen Receives Orphan Designation From FDA

Jul 27, 2012

TGF-β2 inhibitor has gained market exclusivity in the USA for a third aggressive cancer indication The biopharmaceutical company Antisense Pharma GmbH announces that the US Food and Drug Administration (FDA) has granted Orphan Drug designation for its investigational oncology antisense compound trabedersen to treat malignant melanoma... Read More

Risk For Basal Cell Carcinoma Can Be Chronic

Jul 27, 2012

In the powerful sunlight of July, newly published results from a large study of people at high risk for basal cell carcinoma support the emerging view of the nation's most common cancer as a chronic ailment that often repeatedly afflicts older people but for which the seeds may be planted in youth. The research also found a new association with eczema... Read More

Center Researchers Shed Light On New Multiple Myeloma Therapy

Jul 27, 2012

Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal... Read More

Leukaemia Patients Will Benefit From Discovery Of Key Function Of Protein For Obtaining Blood Stem Cells As Source For Transplants

Jul 27, 2012

Researchers from IMIM (Hospital del Mar Medical Research Institute) have deciphered the function executed by a protein called β-catenin in generating blood tissue stem cells. These cells, also called haematopoietic, are used as a source for transplants that form part of the therapies to fight different types of leukaemia... Read More

Potential To Improve Human Cancer Studies Using Novel Pig Model

Jul 26, 2012

A naturally occurring line of immunodeficient pigs can support the growth of human tumors injected under their skin, offering a promising new large animal model for studying human cancers and testing new drugs and treatment strategies... Read More

Following Large-scale HPV Vaccination, Human Papillomavirus Types Do Not Replace Others

Jul 26, 2012

Vaccines against human papillomavirus (HPV) are now recommended by the Centers for Disease Control and Prevention for both teenage boys and girls. The vaccine protects against the two most common types of the virus that cause cervical cancer: HPV 16 and 18... Read More

Colon Cancer Alliance And American College Of Radiology Urge Congress To Pass CT Colonography Screening For Colorectal Cancer Act

Jul 26, 2012

A recent study published in the American Journal of Roentgenology has reconfirmed that virtual colonoscopy (CT colonography) is an effective screening tool for colorectal cancer in seniors age 65 and older... Read More

PREPOPIK™ For Colonoscopy Preparation Receives FDA Approval

Jul 26, 2012

New Low-Volume Regimen With 10 Ounces of Prep Solution The U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market PREPOPIK (sodium picosulfate, magnesium oxide, and anhydrous citric acid) for oral solution indicated for cleansing of the colon as a preparation for colonoscopy in adults... Read More

Previous Page   Next Page

For Medical Professionals

  • Overview
  • Patient Forms
  • Industry News

The US Oncology Network

  • For
    Patients
  • Treatments
    & Services
  • Locations
    & Physicians
  • Cancers
    & Blood Diseases
  • For Medical
    Professionals
  • Pharmacy
Florida Cancer Affiliates ©2025 All rights reserved. | Privacy Practices | Verbal Communications Form
Website by 30 Degrees North